Home›Search›Hepatic Oncology

Hepatic Oncology

Taylor and Francis Ltd. · United Kingdom · Est. 2012

ISSN2045-0923eISSN2045-0931

SJR Q3✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Medium Risk

Score Breakdown

✓ WoS ESCI+10

✓ Scopus Q3+12

✓ DOAJ Verified+15

Total47

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.37

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

Total Works

206

Total Citations

2,638

2yr Mean Citedness

2.33

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on hepatocellular carcinoma (HCC), including its diagnosis, treatment, and patient experience. Research covers various therapeutic strategies such as immune checkpoint inhibitors, locoregional therapies, systemic treatments, and novel agents. The scope also extends to understanding the molecular underpinnings of HCC, biomarker research for early detection, and the management of advanced or metastatic disease. Additionally, the journal addresses the impact of HCC on patients' lives and explores treatment patterns and outcomes in real-world settings.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Average · median is 15 wks

SJR Rank

Top 75% in field

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published2012

Annual Volume~ 5 articles / year

StatusActive (last: 2025)

Total Publications206

Publisher OrgFuture Medicine

OA Since2017

Visit Journal Website

Submission Info

Peer ReviewDouble-blind

Review Time~13 weeks

Acceptance Rate—

OA LicenseCC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

LOCKSSPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2045-0923 / 2045-0931

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

LOCKSS, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2018

2019

2020

2021

2022

2023

2024

2025

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HepatologyQ3

OncologyQ3

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

OncologyHepatology

Research Topics (OpenAlex)

Hepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentCholangiocarcinoma and Gallbladder Cancer StudiesLiver physiology and pathologyCancer Mechanisms and TherapyHepatitis B Virus StudiesPancreatic and Hepatic Oncology ResearchGallbladder and Bile Duct DisordersColorectal Cancer Treatments and StudiesLiver Disease and Transplantation